文献速递腹部介入USCT

腹壁重建术前侧腹壁超声、肌电图或CT引导肉毒毒素注射:技术及结果综述

Image-guided botulinum toxin injection in the lateral abdominal wall prior to abdominal wall reconstruction surgery: review of techniques and results.
PubMed 文献 · Skeletal Radiol · 2020-07-04

本文综述腹壁重建术前影像引导肉毒毒素注射技术,用于腹壁缺损/巨大腹壁疝术前化学性组分分离。肉毒毒素阻断乙酰胆碱释放致侧腹壁肌肉松弛延长,提高筋膜闭合率并降低复发率。常用剂量为onabotulinumtoxinA 200-300单位或abobotulinumtoxinA 500单位,生理盐水2:1稀释,至少术前2周注射,至少双侧腹外斜肌和腹内斜肌各三点共六点注射;美国FDA尚未批准该适应证,文献报道仅轻微并发症。

要点

  • 腹壁重建术前至少2周行侧腹壁肉毒毒素注射,可提高筋膜闭合率并降低复发率。
  • 常用剂量为onabotulinumtoxinA 200-300单位或abobotulinumtoxinA 500单位,生理盐水2:1稀释。
  • 至少双侧腹外斜肌和腹内斜肌各三点共六点注射,可在超声、肌电图或CT引导下完成。

核心结论

  • 术前影像引导肉毒毒素注射是腹壁重建手术的有效辅助手段,可提高筋膜闭合率并降低复发率。
  • 美国FDA目前尚未批准肉毒毒素用于腹壁重建,但文献报道其安全性良好,仅见轻微并发症。

研究设计与样本

  • 本文为综述,总结腹壁重建术前影像引导肉毒毒素注射的技术与结果。
  • 纳入文献涉及腹壁缺损/巨大腹壁疝患者,注射可在超声、肌电图或CT引导下完成。

诊断标准与关键数值

  • 常用剂量为onabotulinumtoxinA(Botox®)200-300单位或abobotulinumtoxinA(Dypsort®)500单位,生理盐水2:1稀释。
  • 注射应至少在腹壁重建术前2周进行,以获得术中最大效果。
  • 至少注射双侧腹外斜肌和腹内斜肌各三点,共六点注射。

临床应用与阅片要点

  • 术前影像引导肉毒毒素注射可作为腹壁重建的辅助手段,通过化学性组分分离使侧腹壁肌肉松弛延长。
  • 注射靶点为双侧腹外斜肌和腹内斜肌,至少各三点共六点,可在超声、肌电图或CT引导下完成。
  • 美国FDA尚未批准该适应证,文献报道仅轻微并发症。

局限性

  • 美国FDA目前尚未批准肉毒毒素用于腹壁重建。
  • 文献报道仅见轻微并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Ventral hernias represent the most common complication after abdominal surgery. Loss of domain and/or large ventral hernias in patients are especially challenging for surgeons to manage, but preoperative image-guided botulinum toxin injection has emerged as an effective adjunct to abdominal wall surgery. Loss of domain is caused by chronic muscle retraction of the lateral abdominal wall and leads to an irreducible protrusion of abdominal viscera into the hernia sac. Botulinum toxin can be used in the oblique muscles as a chemical component relaxation technique to aid abdominal wall reconstruction. Intramuscular botulinum toxin injection causes functional denervation by blocking neurotransmitter acetylcholine release resulting in flaccid paralysis and elongation of lateral abdominal wall muscles, increasing the rate of fascial closure during abdominal wall reconstruction, and decreasing recurrence rates. In total, 200-300 units of onabotulinumtoxinA (Botox®) or 500 units of abobotulinumtoxinA (Dypsort®) in a 2:1 dilution with normal saline is most commonly used. Botulinum toxin can be injected with ultrasonographic, EMG, or CT guidance. Injection should be performed at least 2 weeks prior to abdominal wall reconstruction, for maximal effect during surgery. At minimum, botulinum toxin should be injected into the external and internal oblique muscles at three separate sites bilaterally for a total of six injections. Although botulinum toxin use for abdominal wall reconstruction is currently not indicated by the Food and Drug Administration, it is safe with only minor complications reported in literature.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Deerenberg EB, Elhage SA, Raible RJ, et al. Image-guided botulinum toxin injection in the lateral abdominal wall prior to abdominal wall reconstruction surgery: review of techniques and results. Skeletal Radiol. 2020. PMID: 32621063. doi:10.1007/s00256-020-03533-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。